当前位置:公众访问 >页面
简体中文 / English
1.Screening
1.Management for Progress
2.Inclusion Criteria

Patients who replies "No" to any of the above questions will not enter the study

Doctor's signature

Date

yyyy-mm-dd

1. Patients with either II-degree debrided burn wound or donor site

3. Ages between 18~65 years old

3.Exclusion Criteria

Patients who replies "Yes" to any of the above questions will not enter the study

Doctor's signature

Date

yyyy-mm-dd

2.Baseline
1.Management for Progress
2.General Information

Other diseases

If yes, please describe

If yes, please describe

History of allergic disease

If yes, please describe

If yes, please describe

End Date

Start Date

Doctor's signature

Date

yyyy-mm-dd

Pulse rate

次/分

Marital status

Date of birth

yyyy-mm-dd

Education level

Name of Drug

Systolic pressure (SP)

mmHg

Respiratory rate

次/分

Grouping

Route of Administration

Diastolic pressure (DP)

mmHg

Dosage per Day

3.Physical Examination

Wound Location

Signs and Symptoms

Wound Bed (erythema)

Wound Bed (exudation)

Wound Bed (bleeding)

Wound Type

Wound Surface Area

cm2

4.Lab Investigations

Uric acid

μmol/L

Creatinine

μmol/L

Urea nitrogen

mmol/L

Serum albumin

g/L

Serum bilirubin

μmol/L

AST

U/L

ALT

U/L

Urine protein

g/L (或定性)

Urine red cell

个/μL (或定性)

Urine WBC

个/μL (或定性)

PLT

X10*9/L

Hb

g/L

RBC

X10^12/L

WBC

X10*9/L

Routine Urinalysis

Routine Blood Test

Date of test

yyyy-mm-dd

Liver Function Test

Date of test

yyyy-mm-dd

Renal Function Test

Date of test

Date of examination

yyyy-mm-dd

3.In the process of the treatment
1.Treatment Record
4.At the end of the treatment
1.Management for Progress
5.SOPs
1.Treatment SOP
6.Research team
1.Institutions
7.Design, Methods
1.Calculations of sample size